IGF-1 LR3 protocol & vial guide
Long R3 insulin-like growth factor I (experimental analogue)
IGF-1 LR3 is an engineered IGF-1 analogue investigated mainly in structural, cell-culture and animal research. The verified 1 mg Peak vial is labelled for laboratory research only; it is not the approved mecasermin medicine and has no established human administration protocol.
IGF-1 LR3 · vial at a glance
A vial size describes labelled content, not a dose. The example volume above is arithmetic context only; it is not a verified diluent choice or preparation instruction for a supplier product.
Exact-match Peak Peptides vial imageReported schedule and evidence context
Long R3 IGF-I has been examined for altered IGF-binding-protein interactions and biological responses in experimental models. The authorised Australian mecasermin product contains a different molecule and formulation. No published source validates a human dose, route, mixing method or escalation for Peak's research-only 1 mg LR3 vial.
Review primary sourceNo validated human schedule is available for this compound. The published preclinical experiment must not be converted into personal administration directions.
For research-only formulations, a separate licensed medicine or study does not validate a human regimen for the supplier vial. Clinical decisions require a qualified professional and the correct licensed product.
Preparation: what to verify first
There is no single diluent, mixing method or storage period suitable for every peptide. Follow the exact formulation's qualified instructions instead of applying this chart to a different vial.
Confirm vial identity
Check the compound, labelled quantity, lot, seal, expiry and certificate or insert before planning any calculation.
Check the specified diluent
Use only the formulation-specific diluent and volume supported by the product instructions. Bacteriostatic water is not universally compatible.
Check the resulting solution
Use the labelled mixing and inspection method. Stop if an intended clear solution is cloudy, particulate, discoloured or otherwise abnormal.
Document and store
Record the product, volume and date, then use its validated storage and discard period. Do not infer a universal shelf life.
Concentration and volume calculator
Keep mass and volume separate
Concentration = labelled mass ÷ final liquid volume. A U-100 marking measures liquid volume (100 markings = 1 mL), not a peptide amount or an International Unit of activity.
The calculator checks arithmetic. It does not select a dose, establish compatibility or validate a research product for injection.
Evidence, handling and limitations
Research mechanism
Long R3 IGF-I was engineered to change its interactions with IGF binding proteins. Cell and animal studies investigate IGF1R-mediated signalling; they do not establish a clinical effect or a validated human pharmacokinetic half-life for this research vial.
Handling and storage
Storage temperature, light protection, diluent compatibility and discard period must be confirmed for the precise formulation and lot. Do not carry a shelf life from an approved pen or another compound to a research vial.
This IGF-1 LR3 research vial is not the ARTG-registered mecasermin medicine and has no approved human treatment instructions. No clinical benefit or safety claim is implied for research-only material.
Research suppliers and product identity
Open the specific product page to confirm current vial strength, formulation, batch documentation and legal use category. A supplier listing does not make a research reagent an approved medicine.
Peak Peptides Australia and Pure Performance Australia links are independently tracked in the site analytics.
